Enzyme inhibitory potential of Ligustrum lucidum Aiton berries

Detalhes bibliográficos
Autor(a) principal: Paula, Vanessa
Data de Publicação: 2019
Outros Autores: Delgado, Teresa, Campos, M.G., Anjos, O., Estevinho, Letícia M.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.11/6552
Resumo: Ligustrum lucidum Aiton and its berries have been used in Chinese traditional medicine for around two thousand years. In the present study, L. lucidium berries harvested in two regions of Portugal were studied. Haemolytic activity and inhibition of oxidative haemolysis as well as the enzyme inhibitory activities (α-amylase enzyme and acetylcholinesterase) were assessed. Results suggest that the different biological activities varied according to the region where samples were collected. Results demonstrated that the sample obtained from region R1 was the most efficient extract for all parameters evaluated, presenting the lowest values of IC50, 10.67 ± 0.46 μg/mL for the inhibition of erythrocyte oxidative haemolysis, 58.28 ± 3.77 μg/mL for the α-amylase enzyme and 67.67 ± 2.10 μg/mL for the acetylcholinesterase inhibition. L. Lucidum berries may be an interesting source of compounds for use in the development of the therapeutic armamentarium for diseases where enzymatic disruption is believed to play a role
id RCAP_1ee1a5c6b519b401afee8274b5c1c3bc
oai_identifier_str oai:repositorio.ipcb.pt:10400.11/6552
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Enzyme inhibitory potential of Ligustrum lucidum Aiton berriesLigustrum lucidumAiton berriesDiabetesAlzheimer’s diseaseEnzyme inhibitory potentialLigustrum lucidum Aiton and its berries have been used in Chinese traditional medicine for around two thousand years. In the present study, L. lucidium berries harvested in two regions of Portugal were studied. Haemolytic activity and inhibition of oxidative haemolysis as well as the enzyme inhibitory activities (α-amylase enzyme and acetylcholinesterase) were assessed. Results suggest that the different biological activities varied according to the region where samples were collected. Results demonstrated that the sample obtained from region R1 was the most efficient extract for all parameters evaluated, presenting the lowest values of IC50, 10.67 ± 0.46 μg/mL for the inhibition of erythrocyte oxidative haemolysis, 58.28 ± 3.77 μg/mL for the α-amylase enzyme and 67.67 ± 2.10 μg/mL for the acetylcholinesterase inhibition. L. Lucidum berries may be an interesting source of compounds for use in the development of the therapeutic armamentarium for diseases where enzymatic disruption is believed to play a roleRepositório Científico do Instituto Politécnico de Castelo BrancoPaula, VanessaDelgado, TeresaCampos, M.G.Anjos, O.Estevinho, Letícia M.2019-06-20T23:42:49Z20192019-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.11/6552eng10.3390/molecules24071283info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-02-10T01:48:11Zoai:repositorio.ipcb.pt:10400.11/6552Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T16:37:07.663646Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Enzyme inhibitory potential of Ligustrum lucidum Aiton berries
title Enzyme inhibitory potential of Ligustrum lucidum Aiton berries
spellingShingle Enzyme inhibitory potential of Ligustrum lucidum Aiton berries
Paula, Vanessa
Ligustrum lucidum
Aiton berries
Diabetes
Alzheimer’s disease
Enzyme inhibitory potential
title_short Enzyme inhibitory potential of Ligustrum lucidum Aiton berries
title_full Enzyme inhibitory potential of Ligustrum lucidum Aiton berries
title_fullStr Enzyme inhibitory potential of Ligustrum lucidum Aiton berries
title_full_unstemmed Enzyme inhibitory potential of Ligustrum lucidum Aiton berries
title_sort Enzyme inhibitory potential of Ligustrum lucidum Aiton berries
author Paula, Vanessa
author_facet Paula, Vanessa
Delgado, Teresa
Campos, M.G.
Anjos, O.
Estevinho, Letícia M.
author_role author
author2 Delgado, Teresa
Campos, M.G.
Anjos, O.
Estevinho, Letícia M.
author2_role author
author
author
author
dc.contributor.none.fl_str_mv Repositório Científico do Instituto Politécnico de Castelo Branco
dc.contributor.author.fl_str_mv Paula, Vanessa
Delgado, Teresa
Campos, M.G.
Anjos, O.
Estevinho, Letícia M.
dc.subject.por.fl_str_mv Ligustrum lucidum
Aiton berries
Diabetes
Alzheimer’s disease
Enzyme inhibitory potential
topic Ligustrum lucidum
Aiton berries
Diabetes
Alzheimer’s disease
Enzyme inhibitory potential
description Ligustrum lucidum Aiton and its berries have been used in Chinese traditional medicine for around two thousand years. In the present study, L. lucidium berries harvested in two regions of Portugal were studied. Haemolytic activity and inhibition of oxidative haemolysis as well as the enzyme inhibitory activities (α-amylase enzyme and acetylcholinesterase) were assessed. Results suggest that the different biological activities varied according to the region where samples were collected. Results demonstrated that the sample obtained from region R1 was the most efficient extract for all parameters evaluated, presenting the lowest values of IC50, 10.67 ± 0.46 μg/mL for the inhibition of erythrocyte oxidative haemolysis, 58.28 ± 3.77 μg/mL for the α-amylase enzyme and 67.67 ± 2.10 μg/mL for the acetylcholinesterase inhibition. L. Lucidum berries may be an interesting source of compounds for use in the development of the therapeutic armamentarium for diseases where enzymatic disruption is believed to play a role
publishDate 2019
dc.date.none.fl_str_mv 2019-06-20T23:42:49Z
2019
2019-01-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.11/6552
url http://hdl.handle.net/10400.11/6552
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.3390/molecules24071283
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799130832705683456